RGI-Ab01

N/A

Report date: 2024/11/21 15:50:17

Base Information

Drug NameRGI-Ab01
Drug Alias NameRGI-Ab01RGI-AB-01
ClassificationBiologics
Mechanisms of ActionT lymphocytes inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesREGiMMUNE Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesREGiMMUNE Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A